A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer

A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer

Background: Among the presently available cytotoxic drugs, paclitaxel, in combination with doxorubicin and carboplatin, come under the highly active therapy for metastatic breast cancer. Between the two brands of paclitaxel (Intaxel, which is marketed by Fresenius Kabi and Taxol, the original pa...

Full description

Bibliographic Details
Main Authors: Istvan Lang, Gabor Rubovszky, Zsolt Horvath, Erna Ganofszky, Eszter Szabo, Magdolna Dank, Katalin Boer, Erika Hitre
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2013-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
intaxel
taxol
paclitaxel
metastatic breast cancer
Online Access:https://jcdr.net/articles/PDF/3027/35%20-%204742_PF1(M)_E(C)_F(T)_PF1(M)_PF1(T)_FA(T)_PF1(PUH)_PFA(H).pdf

Internet

https://jcdr.net/articles/PDF/3027/35%20-%204742_PF1(M)_E(C)_F(T)_PF1(M)_PF1(T)_FA(T)_PF1(PUH)_PFA(H).pdf

Similar Items